The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its blockbuster multiple sclerosis drug Copaxone. Copaxone (glatiramer) was once a mainstay of Teva’s portfolio with blockbuster sales… Read More »Teva faces EU antitrust probe over MS drug Copaxone
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West Virginia has decided in favour of AZ in litigation against Mylan Pharmaceuticals and Kindeva, the company… Read More »AstraZeneca breathes sigh of relief as court blocks US Symbicort generic
The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder drug Provigil (modafinil). In a statement the EU said the scheme prevented generic competition for Provigil,… Read More »EU fines Teva and Cephalon €60.5m for ‘pay for delay’ scheme
Teladoc Health has sued competitor American Well for patent infringement. The company is seeking unspecified damages and a ruling that would prevent AmWell from using the telemedicine cart technology that Teladoc claims to hold the patents for.
What effect do chia seeds have on weight loss, blood sugar, cholesterol, blood pressure, and inflammation? We’ve been eating chia seeds for more than 5,000 years. Historically, they are one of the main crops grown in the Western hemisphere. They are exceptionally high in… Read More »Chia Seeds vs. Flaxseeds